Clinical Response (HbA(1c) >= 1% and/or Body Weight >= 5% Reduction) to Semaglutide by Baseline HbA(1c) and Body Weight in the SUSTAIN Program-MedSci.cn

Clinical Response (HbA(1c) >= 1% and/or Body Weight >= 5% Reduction) to Semaglutide by Baseline HbA(1c) and Body Weight in the SUSTAIN Program

Aroda, VR; Larsen, JF; Ostoft, SH; Rea, RR; Sugimoto, D; Ziegler, U; Vilsboll, T

DIABETES, 2019; 68 ():

科室
- - 订阅+
  - 更多科室
工具
服务